Russia became the first country in the world to launch the Coronavirus vaccine last week. However, India is still waiting for the trial data
New Delhi| As the Coronavirus cases rise rapidly, India is eyeing the vaccine being prepared by Oxford-AstraZeneca of Britain and Moderna-NIAID of America. AstraZeneca is working closely with the Serum Institute of India (SII) to bring the vaccine to India.
According to media reports, the National Expert Group, which is responsible for vaccine administration in the country, will hold a second round of meetings with heads of pharma companies involved in vaccine development at 3.30 pm today.
The price of the vaccine will be discussed in the meeting
SII is teaming up with AstraZeneca for clinical trials. Under this deal, most of the 200 people involved in the trial have been tested. In today’s meeting of the National Expert Group, there will be a discussion about the process of buying raw materials and the cost of the vaccine. Companies like SII, Bharat Biotech and Zydus Cadila will attend this meeting. The government will also ascertain the progress of trials of Bharat Biotech and Zydus Cadila.
India awaits Russia’s trial data
Russia became the first country in the world to launch the Coronavirus vaccine last week. However, India is still waiting for the trial data of the Russian vaccine. Nine other vaccine programs are also being monitored, including of Germany and Israel.
The trial of Bharat Biotech vaccine is going ahead, but the process will take 2-3 weeks more. Different batches of people involved in the trial are being given doses of vaccine. Only after giving doses to all, their blood tests will be conducted and changes in the body will be detected. After that, the data analysis will be done.
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.
